Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first661 to 680 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| TFAP2A transcription factor AP-2 alpha | 7020 HGNC:11742 | 1 | 35 | 0 | 0 | 7,125 | 11,024 |
| IDH2 isocitrate dehydrogenase (NADP(+)) 2 | 3418 HGNC:5383 | 1 | 86 | 5 | 50 | 3,863 | 11,010 |
| LGR5 leucine rich repeat containing G protein-coupled receptor 5 | 8549 HGNC:4504 | 1 | 172 | 0 | 0 | 7,979 | 10,968 |
| DNASE1 deoxyribonuclease 1 | 1773 HGNC:2956 | 1 | 192 | 0 | 0 | 5,236 | 10,949 |
| RIPK1 receptor interacting serine/threonine kinase 1 | 8737 HGNC:10019 | 1 | 47 | 1 | 4 | 5,044 | 10,947 |
| FUS FUS DNA/RNA binding protein | 2521 HGNC:4010 | 1 | 55 | 0 | 0 | 4,578 | 10,945 |
| NRP1 neuropilin 1 | 8829 HGNC:8004 | 1 | 99 | 1 | 0 | 5,648 | 10,926 |
| RETN resistin | 56729 HGNC:20389 | 1 | 252 | 0 | 0 | 3,524 | 10,916 |
| F8 coagulation factor VIII | 2157 HGNC:3546 | 1 | 211 | 16 | 520 | 1,743 | 10,914 |
| NTRK2 neurotrophic receptor tyrosine kinase 2 | 4915 HGNC:8032 | 1 | 115 | 14 | 79 | 5,424 | 10,885 |
| XBP1 X-box binding protein 1 | 7494 HGNC:12801 | 1 | 76 | 0 | 0 | 6,423 | 10,852 |
| TNFRSF1B TNF receptor superfamily member 1B | 7133 HGNC:11917 | 1 | 404 | 0 | 0 | 6,068 | 10,850 |
| PKM pyruvate kinase M1/2 | 5315 HGNC:9021 | 1 | 106 | 0 | 0 | 4,288 | 10,845 |
| CD47 CD47 molecule | 961 HGNC:1682 | 1 | 335 | 2 | 47 | 5,006 | 10,844 |
| HDAC2 histone deacetylase 2 | 3066 HGNC:4853 | 1 | 37 | 14 | 659 | 6,050 | 10,706 |
| TNFRSF10B TNF receptor superfamily member 10b | 8795 HGNC:11905 | 1 | 105 | 7 | 30 | 4,223 | 10,705 |
| CFH complement factor H | 3075 HGNC:4883 | 1 | 190 | 0 | 0 | 4,448 | 10,693 |
| DNMT3B DNA methyltransferase 3 beta | 1789 HGNC:2979 | 1 | 52 | 0 | 0 | 5,127 | 10,653 |
| LTA lymphotoxin alpha | 4049 HGNC:6709 | 1 | 345 | 2 | 10 | 5,384 | 10,652 |
| LOC102723407 immunoglobulin heavy variable 4-38-2-like | 102723407 | 0 | 0 | 0 | 0 | 3,635 | 10,649 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=34
{
"data": {
"total": 193990,
"results": [
{
"id": "7020",
"title": "TFAP2A: transcription factor AP-2 alpha",
"summary": "NCBI Gene 7020. 1 protein, 35 patents, 0 drugs, 0 trials, 7,125 NIH grants and 11,024 papers.",
"record": "/library/genes/7020",
"gene_id": 7020,
"symbol": "TFAP2A",
"name": "transcription factor AP-2 alpha",
"hgnc_id": "HGNC:11742",
"counts": {
"proteins": 1,
"patents": 35,
"drugs": 0,
"trials": 0,
"grants": 7125,
"papers": 11024
}
},
{
"id": "3418",
"title": "IDH2: isocitrate dehydrogenase (NADP(+)) 2",
"summary": "NCBI Gene 3418. 1 protein, 86 patents, 5 drugs, 50 trials, 3,863 NIH grants and 11,010 papers.",
"record": "/library/genes/3418",
"gene_id": 3418,
"symbol": "IDH2",
"name": "isocitrate dehydrogenase (NADP(+)) 2",
"hgnc_id": "HGNC:5383",
"counts": {
"proteins": 1,
"patents": 86,
"drugs": 5,
"trials": 50,
"grants": 3863,
"papers": 11010
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=35",
"request_id": "mTutNuvEJrZksH1l"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant